Synphatec

Synphatec is an innovative biotechnology company dedicated to the research and development of original therapeutics in the central nervous system (CNS) field. Built upon the founding team’s 20+ years of expertise in elucidating disease mechanisms in neurobiology and driven by innovation, Synphatec leverages highly specialized CNS pharmacodynamic evaluation models and a rapid screening platform for the druggability assessment of new chemical entities. The company has strategically positioned itself to actively explore areas such as mood disorders, psychiatric disorders, and cognitive impairments, with the goal of delivering clear clinical benefits. By focusing primarily on pipelines with novel targets and mechanisms, Synphatec aims to achieve a steady output and accelerated advancement of candidates ready for Investigational New Drug (IND) applications.